Privacy, Policy and Legal Issues > Public Policy Initiatives

Impact on Reproductive Services for People Facing Hereditary Cancers

FORCE is sharing the below statement in response to the U.S. Supreme Court’s ruling in Dobbs v. Jackson Women’s Health Organization as it relates to reproductive services for people facing hereditary cancers. 

"For 23 years, FORCE has championed access to evidence-based, quality healthcare, while supporting informed decision-making for people affected..."

Expand Medicare beneficiary access to genetic counseling, testing, cancer screening & prevention

Medicare covers genetic testing only for people already diagnosed with cancer, regardless of family history. For individuals with an inherited mutation causing increased cancer risk, coverage of many screenings and risk-reducing interventions is prohibited by law. This legislation will modify the Medicare statutes to allow coverage of these potentially life-saving services.

USPSTF Agrees to Develop National Recommendations 

December 17, 2021 – Today, FORCE was notified that the U.S. Preventive Services Task Force (USPSTF) has agreed to add Lynch syndrome-related cancers to its list of preventive services under consideration. This is a victory for the hereditary cancer community and individuals at increased risk of colorectal and related cancers!

October 27, 2021 - The FDA released new guidance for breast implant labeling and communication today. Aimed at facilitating informed decisions, the agency recommended a 'black box warning,' addition of a decision checklist in the patient brochure, and new implant rupture screening guidelines, changing the timeline and adding ultrasound as an alternative to breast MRI.

Genetic counselors provide crucial information and expertise. But, did you know that these knowledgeable providers are not approved Medicare practitioners? The Access to Genetic Counselor Services Act (H.R. 2144/S. 1450) aims to remedy this issue. Join us in support of genetic counseling coverage for Medicare beneficiaries and expanded access to genetic counseling services for all Americans.

Oral chemotherapy has become the standard of care for many types of cancer. Importantly, most cancer therapies taken by mouth do not have IV or injected alternatives, and are the only option for some patients. Ask your lawmakers to support the Cancer Drug Coverage Parity Act, federal legislation that will ensure equal insurance coverage of cancer treatments regardless of how they are administered.

Take Action Now 2022 Priorities Advocacy Archive

News Briefs

7/11/2022 - Wrote committee leaders in the House and Senate to ask that the Prescription Drug User Fee Act (PDUFA) reauthorization include provisions aimed at creating equitable opportunities for clinical trial participation and improving trial diversity.

6/30/2022 - Urged Congress to address the need for cancer care affordability by passing legislation that permanently extends expanded subsidies in the ACA marketplaces, fixes the Medicaid “coverage gap,” and enacts a cap on out-of-pocket costs for Medicare Part D beneficiaries.

6/8/2022 - Joined over 70 orgs encouraging critical provisions included in Title V of the House Prescription Drug User Fee Act (PDUFA) reauthorization which, if implemented, would improve diversity in clinical trials.


Sponsored By:

Genetech Merck